DEA History Law Therapy 
Veriheal
APRIL 25, 2024
Unfortunately, the implementation of the United States and the subsequent anti-drug laws that followed made it challenging for many tribes to practice this heritage. Also, this is the first time in history a church’s right to import and share its sacrament has been secured without going to trial.
Veriheal
JUNE 29, 2021
Plant medicines and concoctions made from them have been utilized throughout the history of cultures around the world. In the last 100 years, many of the plant therapies that were embraced in history were outlawed by governments around the world and replaced by lab-made synthetic drugs we label medicine. A Push by Patients.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Canna Law Blog
NOVEMBER 27, 2021
So according to the DEA, its abuse potential is high and it has no medical use. Also, according to the DEA, “the history of human experience probably goes back several hundred years since DMT usage is associated with a number of religious practices and rituals.” California Psychedelic Law Update.
Cannabis Law Report
JULY 9, 2021
The state of the law on psychedelic substances is in flux. The use of psychedelic substances to treat mental illness and physical disorders is known as “psychedelic therapy.” Psychedelic therapy is not a fringe phenomenon. Some of the most promising substances, and the law applicable to each, are outlined below: Psilocybin.
Cannabis Law Report
JULY 1, 2021
From their blog… Q&A with Mason Marks on New Psychedelics Law and Regulation Initiative. On June 30th, the Petrie-Flom Center announced the launch of a three-year research initiative , the Project on Psychedelics Law and Regulation (POPLAR) , which is supported by a generous grant from the Saisei Foundation.
Cannabis Law Report
FEBRUARY 28, 2022
Patents on psychedelics raise unique concerns associated with their unusual qualities, history, and regulation. Moreover, because Indigenous communities pioneered many aspects of modern psychedelic therapies, their patenting by Western corporations may promote biopiracy, the exploitation of Indigenous knowledge without compensation.
Cannabis Law Report
APRIL 8, 2022
as a non-profit organization to fulfill the need to broaden psychedelic research, therapy, and develop legal options for psychedelic medicine. In MAPS’ 36th year, we’ll learn if our second Phase 3 study of MDMA-assisted therapy for PTSD was successful. Later that year, Doblin sued the DEA for the first time. Rick Doblin, Ph.D.,
Expert insights. Personalized for you.
109 
Let's personalize your content